- Exchange: Berlin
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Antisense Therapeutics Ltd+ Add to Watchlist
AWY:GR0.057 EUR 0.012 26.67%
As of 02:08:03 ET on 04/01/2015.
Company Profile for Antisense Therapeutics Ltd (AWY)
Antisense Therapeutics Limited develops and markets drugs for treatment of diseases like psoriasis, multiple sclerosis, autoimmune, cancer, metabolic and cardiovascular. The drugs are based on small synthetic genetic molecules. The Company has collaboration with Isis Pharmaceuticals in the United States, which provides the Company access to drug development technology.
Antisense Therapeutics Ltd
Key Executives for Antisense Therapeutics Ltd (AWY)
|Mark P DiamondCEO/Managing Director||Phillip HainsCFO/Secretary|